Ieva Kirchovaite
๐†๐ž๐ง๐จ๐ฆ๐ข๐œ๐ฌ ๐ˆ๐ฌ ๐‚๐ซ๐จ๐ฌ๐ฌ๐ข๐ง๐  ๐ˆ๐ง๐ญ๐จ ๐€๐ง๐ข๐ฆ๐š๐ฅ ๐‡๐ž๐š๐ฅ๐ญ๐ก Genomics isnโ€™t just human medicine anymore. Genetic testing is already changing how we: โ€ข identify hereditary diseases โ€ข select targeted treatments โ€ข plan breeding responsibly In veterinary medicine, adoption is still early. Thatโ€™s the interesting part. ๐Œ๐ฒ ๐ž๐ฑ๐ฉ๐จ๐ฌ๐ฎ๐ซ๐ž: $ILMN (Illumina) โ€” sequencing backbone $VRTX (Vertex Pharmaceuticals Incorporated) โ€” proof that genetics can build durable cash flow $ARKG (ARK Genomic Revolution ETF) โ€” diversified access to long-term genomics growth This isnโ€™t about next quarter. Itโ€™s about how medicine gets practiced 10โ€“20 years from now. @Uogyte $NEOG (Neogen Corporation)
null
.